250 related articles for article (PubMed ID: 36194364)
1. Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research.
Kuo CY; Lin CH; Lane HY
CNS Drugs; 2022 Nov; 36(11):1143-1153. PubMed ID: 36194364
[TBL] [Abstract][Full Text] [Related]
2. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
[TBL] [Abstract][Full Text] [Related]
3. D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy.
Sacchi S; Rosini E; Pollegioni L; Molla G
Curr Pharm Des; 2013; 19(14):2499-511. PubMed ID: 23116391
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia.
Ferraris DV; Tsukamoto T
Curr Pharm Des; 2011; 17(2):103-11. PubMed ID: 21361869
[TBL] [Abstract][Full Text] [Related]
5. Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.
Sershen H; Hashim A; Dunlop DS; Suckow RF; Cooper TB; Javitt DC
Neurochem Res; 2016 Feb; 41(1-2):398-408. PubMed ID: 26857796
[TBL] [Abstract][Full Text] [Related]
6. Assays of D-Amino Acid Oxidase Activity.
Rosini E; Caldinelli L; Piubelli L
Front Mol Biosci; 2017; 4():102. PubMed ID: 29404340
[TBL] [Abstract][Full Text] [Related]
7. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia.
Madeira C; Freitas ME; Vargas-Lopes C; Wolosker H; Panizzutti R
Schizophr Res; 2008 Apr; 101(1-3):76-83. PubMed ID: 18378121
[TBL] [Abstract][Full Text] [Related]
8. Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies.
Szilágyi B; Ferenczy GG; Keserű GM
Expert Opin Drug Discov; 2018 Oct; 13(10):973-982. PubMed ID: 30220232
[TBL] [Abstract][Full Text] [Related]
9. Human d-amino acid oxidase: The inactive G183R variant.
Murtas G; Caldinelli L; Cappelletti P; Sacchi S; Pollegioni L
Biochim Biophys Acta Proteins Proteom; 2018 Jul; 1866(7):822-830. PubMed ID: 29274788
[TBL] [Abstract][Full Text] [Related]
10. Human D-Amino Acid Oxidase: Structure, Function, and Regulation.
Pollegioni L; Sacchi S; Murtas G
Front Mol Biosci; 2018; 5():107. PubMed ID: 30547037
[TBL] [Abstract][Full Text] [Related]
11. The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors.
Smith SM; Uslaner JM; Hutson PH
Open Med Chem J; 2010 May; 4():3-9. PubMed ID: 20648222
[TBL] [Abstract][Full Text] [Related]
12. Coumarin derivatives as inhibitors of d-amino acid oxidase and monoamine oxidase.
Bester E; Petzer A; Petzer JP
Bioorg Chem; 2022 Jun; 123():105791. PubMed ID: 35413582
[TBL] [Abstract][Full Text] [Related]
13. Factors regulating serine racemase and d-amino acid oxidase expression in the mouse striatum.
Takagi S; Balu DT; Coyle JT
Brain Res; 2021 Jan; 1751():147202. PubMed ID: 33171153
[TBL] [Abstract][Full Text] [Related]
14. Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain.
Strick CA; Li C; Scott L; Harvey B; Hajós M; Steyn SJ; Piotrowski MA; James LC; Downs JT; Rago B; Becker SL; El-Kattan A; Xu Y; Ganong AH; Tingley FD; Ramirez AD; Seymour PA; Guanowsky V; Majchrzak MJ; Fox CB; Schmidt CJ; Duplantier AJ
Neuropharmacology; 2011; 61(5-6):1001-15. PubMed ID: 21763704
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice.
Rais R; Thomas AG; Wozniak K; Wu Y; Jaaro-Peled H; Sawa A; Strick CA; Engle SJ; Brandon NJ; Rojas C; Slusher BS; Tsukamoto T
Drug Metab Dispos; 2012 Nov; 40(11):2067-73. PubMed ID: 22837388
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human DAAO variants potentially related to an increased risk of schizophrenia.
Caldinelli L; Sacchi S; Molla G; Nardini M; Pollegioni L
Biochim Biophys Acta; 2013 Mar; 1832(3):400-10. PubMed ID: 23219954
[TBL] [Abstract][Full Text] [Related]
17. Structure-function relationships in human d-amino acid oxidase variants corresponding to known SNPs.
Cappelletti P; Piubelli L; Murtas G; Caldinelli L; Valentino M; Molla G; Pollegioni L; Sacchi S
Biochim Biophys Acta; 2015 Sep; 1854(9):1150-9. PubMed ID: 25701391
[TBL] [Abstract][Full Text] [Related]
18. Physiological functions of D-amino acid oxidases: from yeast to humans.
Pollegioni L; Piubelli L; Sacchi S; Pilone MS; Molla G
Cell Mol Life Sci; 2007 Jun; 64(11):1373-94. PubMed ID: 17396222
[TBL] [Abstract][Full Text] [Related]
19. Lack of Effect of Sodium Benzoate at Reported Clinical Therapeutic Concentration on d-Alanine Metabolism in Dogs.
Popiolek M; Tierney B; Steyn SJ; DeVivo M
ACS Chem Neurosci; 2018 Nov; 9(11):2832-2837. PubMed ID: 29893546
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel spinal dorsal horn astroglial D-amino acid oxidase-hydrogen peroxide pathway involved in morphine antinociceptive tolerance.
Gong N; Li XY; Xiao Q; Wang YX
Anesthesiology; 2014 Apr; 120(4):962-75. PubMed ID: 23928652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
